Table 1 Clinical characteristics of patients
IGFI group (n = 84) | Control group (n = 105) | P value | |
|---|---|---|---|
Gender, n (%) | 0.514 | ||
Male | 48 (57.1) | 55 (52.4) | |
Female | 36 (42.9) | 50 (47.6) | |
Age, yr, mean ± SD | 59.1 ± 11.1 | 60.2 ± 9.8 | 0.478 |
BMI, kg/m2, mean ± SD | 24.6 ± 3.4 | 23.8 ± 2.7 | 0.066 |
ASA score, n (%) | 0.279 | ||
1 | 28 (33.3) | 45 (42.9) | |
2 | 50 (59.5) | 50 (47.6) | |
3 | 6 (7.1) | 10 (9.5) | |
4 | 0 | 0 | |
Previous abdominal operation, n (%) | 0.083 | ||
Yes | 17 (20.0) | 33 (31.4) | |
No | 67 (80.0) | 72 (68.6) | |
Preoperative neoadjuvant therapy, n (%) | |||
NACT | 14 (16.7) | 30 (28.6) | 0.054 |
No | 70 (83.3) | 75 (71.4) | |
Tumor location, n (%) | 0.761 | ||
Ileocecal junction | 20 (23.8) | 25 (23.8) | |
Ascending colon | 25 (29.8) | 28 (26.7) | |
Hepatic flexure | 9 (10.7) | 18 (17.1) | |
Transverse colon | 12 (14.3) | 10 (9.5) | |
Splenic flexure | 5 (5.9) | 6 (5.7) | |
Descending colon | 8 (9.5) | 8 (7.6) | |
High sigmoid colon | 5 (5.9) | 10 (9.5) | |